Fibrogen inc

Major-Pharmaceuticals

FGEN


409 Illinois Street
San Francisco , CA 94158

Executive/
Director

Price

  • Last Close
  • $ 0.37
    $ +0.01 2.2 %
    Aug 29, 2024
  • 52-Week High/Low
  • $2.73 - $0.36
  • YTD
  • -58%

  • Trading Volume
  • 37,917
  • Market Cap Full
  • $ 36.4M
  • Shares Outstanding
  • 98.3M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 14.8% -30.1% 15.2% -2.5% 17.4% -5% -7.2% -14.8% 16.5% 165.2%
Q2 -25.1% -22.9% 31% 39.1% -19.2% 4% -23.3% -12.2% -85.5% -8.5%
Q3 -6.7% 26.1% 66.6% -4% -21.8% 8% -61.6% 23.2% -68% -
Q4 39% 3.4% -14.8% -21.4% 21.2% -9% 38% 23.1% 9.4% -
J F M A M J J A S O N D
2024 116.7% -10.9% 37.4% -8.1% - - - - - - - -
2023 47.3% -5.9% -16% -8.3% 0.8% -84.4% -23.7% -53.4% -10.1% -37.3% 2% 60.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%11%-30%121%-2%-5%-15%-62%14%-94%-58%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.78 0.45 0.52 -0.5 -0.53 -0.89 -0.78 -0.68 -0.81
Q2 0.83 0.35 0.48 -0.28 1.26 -0.95 -1.45 -0.78 -0.90
Q3 0.74 0.38 0.50 -0.5 -0.57 0.35 0.54 -0.98 -0.65
Q4 0.85 0.54 0.27 0.25 -1.05 -0.62 -1.45 -0.70 -
A 3.2 1.7 1.8 -1 -0.9 -2.1 -3.1 -3.1 -2.36

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 85.6 88 91.6 93 94.2
Jun 83.5 86.2 89.1 92.1 93.3 97.6
Sep 84.3 86.9 90.4 92.6 93.7 98.2
Dec 85 87.3 91 92.7 94 98.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.5 0.4 0.5 0.1 -
Fixed Asset Turnover 3.8 1.1 4.1 2.2 1.1
Total Asset Turnover 0.2 0.3 0.2 0.3 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 43 -289 64 7.4 87
Equity multiplier -37 0.9 0.1 0.2 0.4